Search
for
Sort by
Research 181–210 of 1000+
- Evaluating combined therapy with myoinositol and D-chiro-inositol in infertility management across PCOS phenotypes: a comprehensive retrospective data analysis
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Can serum vaspin levels predict clomiphene resistance in infertile women with PCOS?
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- CLINICAL PROFILE AND OUTCOMES OF PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
- Factors associated with early-onset androgenetic alopecia: A scoping review
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Acupuncture improves anxiety and depression in patients with polycystic ovary syndrome: a systematic evaluation and meta-analysis
- Association of Gly972Arg variant of insulin receptor subtrate-1 and Gly1057Asp variant of insulin receptor subtrate-2 with polycystic ovary syndrome in the Chinese population
- Obesity and polycystic ovary syndrome
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome
- Endocrinology
- The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
- Finasteride treatment of premature androgenetic alopecia
- Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
- 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population.
- Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: An inherited form of male pseudohermaphroditism
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population
- Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
- Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
- E-Poster